Form 4: Zimmer Biomet Executive Wilfred van Zuilen Reports Stock Transactions

Wilfred van Zuilen, Group President, EMEA at Zimmer Biomet, reports acquisition and disposal of common stock and restricted stock units.

Summary

• On February 18, 2025, Wilfred van Zuilen, Group President, EMEA of Zimmer Biomet Holdings, Inc., reported transactions involving the company's common stock and restricted stock units (RSUs).
• Van Zuilen acquired 9,174 shares of common stock upon the vesting of restricted stock units on February 18, 2025.
• He also disposed of 2,414 shares to cover tax withholding obligations related to the vesting of the RSUs at a price of $101 per share.
• Additionally, he acquired 132 shares under the Employee Stock Purchase Plan through February 18, 2025.
• Following these transactions, Van Zuilen directly owns 16,135 shares of Zimmer Biomet common stock and 0 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation. There are no indications of unusual or concerning activity.

Positives

• The acquisition of shares through RSU vesting and the Employee Stock Purchase Plan indicates a continued investment in the company by the executive.

Negatives

• The disposal of shares to cover tax obligations, while standard, slightly reduces the executive's holdings.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's common for executives to receive stock-based compensation and subsequently sell shares to cover tax liabilities.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.

Key Dates

Keywords

Zimmer Biomet, ZBH, Wilfred van Zuilen, Form 4, Stock Transaction, Restricted Stock Units, Employee Stock Purchase Plan, Insider Trading